Delivery Order SPE2DB22D3004-SPE2DB24FQF37
Award Date 5/2/24
Potential Completion Date 5/3/24
Potential Value $3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $13,429.67, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, with a completion date of February 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award, valued at $1,644.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of May 10, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,694.10, is for the delivery of Lidocaine 5% Patches. This is a firm fixed-price delivery order contract with a completion date of February 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $2,745.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of Lidocaine 5% Patches, a pharmaceutical product used for pain management. The contract has an ultimate completion date of January 26, 2024, and is a firm-fixed-price contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award, valued at $2,388.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patch 30s, a topical anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 16, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp has been awarded multiple...
- This federal contract award, valued at $2,528.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a completion date of February 15, 2024. This award is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award, valued at $1,278.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 27, 2025. The contract does not have a set-aside...
- This federal contract award, valued at $2,883.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product. The contract has a firm fixed price and is designated as a delivery order, with a completion date of February 8, 2024. The award was made without any set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $1,640.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026....
- This federal contract award, valued at $1,243.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% patches, with an ultimate completion date of April 26, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...